Interim report January 1 – March 31, 2022
FIRST QUARTER (JANUARY – MARCH 2022)• Order intake SEK 272.5 M (145.1)• Net sales SEK 208.1 M (162.1)• Operating profit SEK 29.6 M (12.3)• Profit after tax SEK 19.3 M (7.1)• Earnings per share before/after dilution SEK 0.56 (0.21)• Cash flow SEK 35.3 M (32.8)• Order backlog SEK 1,488.7 M (1,207.1) at the end of the period SIGNIFICANT EVENTS DURING THE FIRST QUARTER• In January, RaySearch signed an agreement with Proton International Arkansas to provide RayStation at the UAMS Radiation Oncology Center.• In February, the Charles-Le Moyne